Organigram Holdings Inc.
OGI • NASDAQ
Organigram Holdings Inc. is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO James H. Yamanaka, with a market cap of $178.6M.
CEOJames H. Yamanaka
Market Cap$178.6M
Drug Manufacturers - Specialty & Generic
Healthcare
Employees987.0
Websiteorganigram.ca
Next Earnings
Upcoming earnings announcement for Organigram Holdings Inc.
Date
Monday, May 11, 2026 (in a month)
Timing
Before Market Open (6:00 AM New York)
Fiscal Period
Q2 2026
EPS Estimate
-$0.01
Revenue Estimate
$52.1M
Earnings History
Past 12 earnings reports for Organigram Holdings Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 10, 2026 | Q1 2026 | $0.10Est: -$0.01 | +1100.0% | $45.6MEst: $53.5M | -14.9% | — |
| Dec 16, 2025 | Q4 2025 | -$0.21Est: -$0.01 | -1950.0% | $58.2MEst: $53.1M | +9.4% | — |
| Aug 13, 2025 | Q3 2025 | -$0.03Est: -$0.01 | -240.0% | $51.1MEst: $48.3M | +5.8% | — |
| May 12, 2025 | Q2 2025 | $0.22Est: -$0.03 | +833.3% | $45.7MEst: $42.3M | +8.1% | — |
| Feb 11, 2025 | Q1 2025 | -$0.14Est: -$0.03 | -366.7% | $30.6MEst: $34.2M | -10.5% | — |
| Dec 18, 2024 | Q4 2024 | -$0.08Est: -$0.03 | -166.7% | $32.8MEst: $31.5M | +4.2% | — |
| Aug 13, 2024 | Q3 2024 | $0.02Est: -$0.05 | +140.0% | $30.0MEst: $28.6M | +5.0% | — |
| May 14, 2024 | Q2 2024 | -$0.22Est: -$0.06 | -266.7% | $27.9M | — | — |
| Feb 13, 2024 | Q1 2024 | -$0.11Est: -$0.09 | -22.2% | $26.8MEst: $28.0M | -4.3% | — |
| Dec 19, 2023 | Q4 2023 | -$0.07Est: -$0.10 | +30.0% | $34.3MEst: $29.5M | +16.3% | — |
| Jul 13, 2023 | Q3 2023 | -$0.05Est: -$0.04 | -25.0% | $24.2MEst: $31.9M | -24.2% | — |
| Apr 11, 2023 | Q2 2023 | -$0.07Est: -$0.04 | -75.0% | $29.3MEst: $32.2M | -9.1% | — |